Table 2.
The relationship between DGCR5 expression level (ΔCt) and clinicopathological features of LC patients
| Characteristics | No. of patients (%) | DGCR5 | |
|---|---|---|---|
|
| |||
| Mean ± SD | P value | ||
| Total no. of patients | 48 | ||
| Age (year) | |||
| > 60 | 35 (72.9) | 11.28 ± 1.04 | 0.615 |
| ≤ 60 | 13 (27.1) | 11.46 ± 1.24 | |
| Gender | |||
| Male | 38 (79.2) | 11.05 ± 1.49 | 0.444 |
| Female | 10 (20.8) | 11.48 ± 1.85 | |
| Lymphatic metastasis | |||
| N0 | 29 (60.4) | 11.14 ± 1.24 | 0.023* |
| N1-N2 | 19 (39.6) | 11.99 ± 1.19 | |
| Distal metastasis | |||
| M0 | 39 (81.3) | 11.21 ± 1.28 | 0.189 |
| M1 | 9 (18.7) | 11.85 ± 1.38 | |
| TNM stage | |||
| 0 & I & II | 40 (83.3) | 11.25 ± 1.78 | 0.287 |
| III & IV | 8 (16.7) | 12.04 ± 2.34 | |
*
Indicates P < 0.05.